EN | RU
EN | RU

Help Support

Back
A study to evaluate the effectiveness of Vitamin D supplementation in knee OA A study to evaluate the effectiveness of Vitamin D supplementation in knee OA
A study to evaluate the effectiveness of Vitamin D supplementation in knee OA A study to evaluate the effectiveness of Vitamin D supplementation in knee OA

What's new?

Vitamin D supplementation should be reconsidered in patients with knee OA as there is a lack of data supporting its efficacy in decreasing disease progression and improving the management of knee OA.

Osteoarthritis (OA) is an age-related degenerative condition of joints, which mainly involves cartilage, joint lining, ligaments, muscle, and underlying bone. The most commonly affected joint is knee joint, which can lead to disability in the elderly. Knee OA usually results due to the deficiency of vitamin D. However, data regarding the efficacy of vitamin D supplementation in knee osteoarthritis are contradictory.

A group of investigators conducted a systematic literature review to find out the outcomes of vitamin D supplementation in managing knee osteoarthritis. The electronic literature searches of studies from inception to 6th July 2016 was performed in databases like PubMed, Embase, and Cochrane CENTRAL. Cochrane risk of bias tool was adopted to check the quality of included Randomized Controlled Trials (RCTs). The primary outcome measures were changes in Western Ontario and McMaster Universities (WOMAC) index, Visual Analog Scale (VAS) and Functional Pain Score (FPS). Secondary outcomes included changes in tibial cartilage thickness, joint space width, and safety profile. Participants were divided randomly either to the treatment or placebo group. Participants were provided cholecalciferol [dose range of 800–60,000 IU] as an intervention using the oral route, with an exception in the one study where participants were given Ergocalciferol.

The remarkable increase was observed in the serum level of Vitamin D among the treatment group as compared to the placebo group. No notable reduction in pain and function was reported on WOMAC scale except in one study. There was no considerable difference noticed in WOMAC stiffness in any study. VAS assessment was done in three studies, where two showed statistically significant improvement in knee pain.

Safety data was reported in 3 RCTs, and a single incidence of calculus ureteric and hip fracture was found to be linked to the drug. Evidence obtained from RCTs are not sufficient enough to support the use of vitamin D supplementation in patients suffering from knee osteoarthritis.

Source:

Rheumatology International

Article:

Vitamin D supplementation for the management of knee osteoarthritis: a systematic review of randomized controlled trials

Authors:

Hussain S, Singh A et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en
Try: